Aeglea BioTherapeutics, Inc. holds $7.1 million in cash deposits with Silicon Valley Bank (SVB), which has been closed by the FDIC. The FDIC will transfer insured deposits to the Deposit Insurance National Bank of Santa Clara (DINB) and uninsured depositors will receive a receivership certificate for the remaining amount of their funds.